Our study highlights that TUBA1B is significantly overexpressed in most cancers compared to normal samples and strongly linked to poor prognosis, particularly in cancers such as ACC, BLCA, BRCA, KICH, LGG, LIHC, LUAD, MESO, and SARC. This evidence concerns the gene TUBA1B and cancer.